| Recruiting | Thailand HDV Cohort HDV | — | 2023-01-30 |
| Terminated | Microneedles for Diagnosis of LTBI Latent Tuberculosis | N/A | 2021-04-08 |
| Active Not Recruiting | Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals HIV-infected Participants With Latent TB Infection in High TB Burden Country | Phase 3 | 2019-08-15 |
| Recruiting | Efficacy, Safety and Pharmacokinetics of DTG with RIF HIV/TB Coinfection | Phase 2 | 2019-06-25 |
| Completed | Self-Assessment Tuberculin Skin Test Tuberculin Skin Test | — | 2019-06-04 |
| Completed | Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricit HIV | Phase 3 | 2019-05-01 |
| Unknown | Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV Compensated Cirrhosis | Phase 4 | 2018-08-01 |
| Completed | Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly HIV, Tuberculosis | Phase 2 | 2015-06-01 |
| Completed | RH and Adolescents Reproductive Health | — | 2013-03-01 |
| Completed | Abacavir and Lamivudine PK in Children HIV | Phase 2 / Phase 3 | 2012-07-01 |
| Completed | Children With HIV and Asthma (CHIVAS) T Cell Response to Asthma in HIV-infected Patients Before and After Starting Treatment | N/A | 2011-09-01 |
| Completed | Atazavanir/Ritonavir-based HAART in Children HIV | Phase 2 | 2011-07-01 |
| Active Not Recruiting | Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals Tuberculosis | N/A | 2011-06-06 |
| Completed | Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) HIV Infections | Phase 4 | 2011-05-01 |
| Completed | Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL) HIV-infected Children | Phase 3 | 2011-03-01 |
| Completed | Meaning of Life in HIV-infected Youths Meaning of Life | N/A | 2011-02-01 |
| Completed | Second-line Therapy Treatment Failure of Second-line ART in Asian HIV-infected Children | — | 2011-01-01 |
| Completed | HPV in Adolescents HPV Infection, Cervical/Anal Dysplasia | — | 2010-12-01 |
| Completed | TDF Long Term Study HIV-infected Thai Children | — | 2010-12-01 |
| Completed | Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-in HIV Infections, Tuberculosis | Phase 2 | 2010-11-01 |
| Completed | A Sub-study of PREDICT Neurodevelopment Protocol Neurocognitive Development | — | 2010-10-01 |
| Completed | Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy | — | 2010-08-01 |
| Completed | PK TDF in Thai HIV-infected Children HIV | N/A | 2010-06-01 |
| Completed | Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz HIV | Phase 2 | 2010-06-01 |
| Completed | Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children HIV | N/A | 2010-04-01 |
| Completed | Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children HIV-1 Infections | Phase 2 | 2010-04-01 |
| Completed | Pharmacokinetics of Low Dose Raltegravir HIV Infections | Phase 2 | 2010-04-01 |
| Completed | Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation Renal Function, HIV Infection | — | 2010-03-01 |
| Completed | Lopinavir (LPV) Dose Reduction HIV-1 Infections | Phase 1 / Phase 2 | 2009-07-01 |
| Completed | The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children HIV Infections, Varicella-zoster Virus | Phase 4 | 2009-06-01 |
| Completed | Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV) HIV Infections | — | 2009-05-01 |
| Completed | Hepatitis B Vaccination (HBV) in HIV Infected Children HIV Infections | Phase 2 | 2009-04-01 |
| Completed | Progress Pediatric Study HIV, Depression | — | 2009-01-01 |
| Completed | Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women HIV Infections | Phase 2 | 2008-06-01 |
| Completed | Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRT HIV Infections | Phase 4 | 2008-05-01 |
| Completed | Pharmacokinetics of Low Dose Ritonavir HIV Infections | Phase 1 / Phase 2 | 2008-01-01 |
| Completed | TDM of Generic Lopinavir/Ritonavir 200/50 mg HIV | Phase 2 | 2008-01-01 |
| Completed | Progress Adult Study HIV, Depression | — | 2007-12-01 |
| Completed | Lopinavir/Ritonavir Monotherapy in Children HIV Infections | Phase 4 | 2007-11-01 |
| Completed | Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral The HIV Infection, HIV Infections | — | 2007-10-01 |
| Completed | Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy HIV Infections | — | 2007-09-01 |
| Completed | A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects HIV Infections | Phase 2 | 2007-06-01 |
| Completed | Dose Reduction of Lopinavir in Children HIV Infections | Phase 2 | 2007-04-01 |
| Completed | Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 HIV Infections | — | 2007-03-01 |
| Completed | Bioequivalence Study of Generic GPO Ritonavir Versus Norvir® Healthy | Phase 1 | 2007-01-01 |
| Completed | Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients HIV Infections | Phase 1 / Phase 2 | 2007-01-01 |
| Completed | The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin HIV Infections, Tuberculosis | Phase 1 / Phase 2 | 2006-12-01 |
| Completed | A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection Hepatitis b Virus | N/A | 2006-12-01 |
| Completed | Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r HIV Infections | — | 2006-02-01 |
| Completed | Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs HIV Infections | N/A | 2006-01-01 |
| Completed | Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy HIV Infections, Tuberculosis | Phase 2 | 2005-10-01 |
| Completed | Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection Hepatitis B Virus, HIV Infections | Phase 2 | 2005-04-01 |
| Completed | HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection HIV, Hepatitis-B | — | 2005-04-01 |
| Completed | Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity IDV Associated Nephrotoxicity | Phase 2 | 2004-05-01 |
| Completed | The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients HIV Infections | Phase 2 | 2004-03-01 |
| Completed | A PK and Salvage Study for Children With HIV-infection HIV Infections | Phase 4 | 2003-10-01 |
| Completed | A Prospective Cohort of Children With HIV Infection HIV Infections | — | 2003-03-01 |
| Recruiting | A Long-term Follow-up of the HIV-NAT Cohort HIV Infections | — | 2002-11-01 |
| Withdrawn | Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir® HIV Infections | Phase 1 / Phase 2 | — |
| Withdrawn | Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID | Phase 2 / Phase 3 | — |